Cargando…

Therapeutic potential of PPARγ natural agonists in liver diseases

Peroxisome proliferator‐activated receptor gamma (PPARγ) is a vital subtype of the PPAR family. The biological functions are complex and diverse. PPARγ plays a significant role in protecting the liver from inflammation, oxidation, fibrosis, fatty liver and tumours. Natural products are a promising p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Liwei, Guo, Chuanyong, Wu, Jianye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077554/
https://www.ncbi.nlm.nih.gov/pubmed/32031298
http://dx.doi.org/10.1111/jcmm.15028
_version_ 1783507458875981824
author Wu, Liwei
Guo, Chuanyong
Wu, Jianye
author_facet Wu, Liwei
Guo, Chuanyong
Wu, Jianye
author_sort Wu, Liwei
collection PubMed
description Peroxisome proliferator‐activated receptor gamma (PPARγ) is a vital subtype of the PPAR family. The biological functions are complex and diverse. PPARγ plays a significant role in protecting the liver from inflammation, oxidation, fibrosis, fatty liver and tumours. Natural products are a promising pool for drug discovery, and enormous research effort has been invested in exploring the PPARγ‐activating potential of natural products. In this manuscript, we will review the research progress of PPARγ agonists from natural products in recent years and probe into the application potential and prospects of PPARγ natural agonists in the therapy of various liver diseases, including inflammation, hepatic fibrosis, non‐alcoholic fatty liver and liver cancer.
format Online
Article
Text
id pubmed-7077554
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70775542020-03-19 Therapeutic potential of PPARγ natural agonists in liver diseases Wu, Liwei Guo, Chuanyong Wu, Jianye J Cell Mol Med Reviews Peroxisome proliferator‐activated receptor gamma (PPARγ) is a vital subtype of the PPAR family. The biological functions are complex and diverse. PPARγ plays a significant role in protecting the liver from inflammation, oxidation, fibrosis, fatty liver and tumours. Natural products are a promising pool for drug discovery, and enormous research effort has been invested in exploring the PPARγ‐activating potential of natural products. In this manuscript, we will review the research progress of PPARγ agonists from natural products in recent years and probe into the application potential and prospects of PPARγ natural agonists in the therapy of various liver diseases, including inflammation, hepatic fibrosis, non‐alcoholic fatty liver and liver cancer. John Wiley and Sons Inc. 2020-02-07 2020-03 /pmc/articles/PMC7077554/ /pubmed/32031298 http://dx.doi.org/10.1111/jcmm.15028 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Wu, Liwei
Guo, Chuanyong
Wu, Jianye
Therapeutic potential of PPARγ natural agonists in liver diseases
title Therapeutic potential of PPARγ natural agonists in liver diseases
title_full Therapeutic potential of PPARγ natural agonists in liver diseases
title_fullStr Therapeutic potential of PPARγ natural agonists in liver diseases
title_full_unstemmed Therapeutic potential of PPARγ natural agonists in liver diseases
title_short Therapeutic potential of PPARγ natural agonists in liver diseases
title_sort therapeutic potential of pparγ natural agonists in liver diseases
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077554/
https://www.ncbi.nlm.nih.gov/pubmed/32031298
http://dx.doi.org/10.1111/jcmm.15028
work_keys_str_mv AT wuliwei therapeuticpotentialofppargnaturalagonistsinliverdiseases
AT guochuanyong therapeuticpotentialofppargnaturalagonistsinliverdiseases
AT wujianye therapeuticpotentialofppargnaturalagonistsinliverdiseases